Remove Big Data Remove Clinical Trials Remove Nurses
article thumbnail

BioXcel Therapeutics Receives FDA Clearance of IND for Phase 2 Trial with BXCL501 for the Treatment of Agitation Associated with DeliriumFifth potential indication for BXCL501, an orally dissolving thin film

The Pharma Data

The Richmond Agitation–Sedation Scale was developed in a collaborative effort with practitioners representing critical care physicians, nurses, and pharmacists and its validation and reliability is well documented. BioXcel Therapeutics, Inc.

Trials 40
article thumbnail

October 24, 2024: APA-SM Trial Joins the NIH Pragmatic Trials Collaboratory

Rethinking Clinical Trials

Kawi is a Lee and Joseph Jamail Distinguished Professor in the Cizik School of Nursing at UTHealth Houston. Bolin is Regents Professor Emerita and a senior professor in the College of Nursing at Texas A&M University. Learn more about the APA-SM trial.

Trials 147